PPTA presents at the 15th Biennial Meeting of the European Society of Immunodeficiencies (ESID 2012) held in collaboration with the International Patient Organisation of Patients with Immunodeficiency (IPOPI) and the International Nurses Group for Immune Deficiency (INGID).

Over 300 patients, policymakers and industry representatives convened in Washington, DC on June 21-22 for the 2012 Plasma Protein Forum. The conference centered on the theme of rare diseases.

A documentary premiered at the June 20th Gala event in Washington, D.C. celebrating PPTA's 20th Anniversary. The  documentary recognizes the significant contributions of PPTA members to patients around the world.

ANNAPOLIS, MD – The Plasma Protein Therapeutics Association (PPTA) is delighted to announce that Europlasma has achieved s.r.o International Quality Plasma Program (IQPP) certification for the Dárcovské centrum Chodov (DCCH) in Prague. This modern facility is the first Czech Republic center to achieve such recognition.

The world is diminished with the passing of Dr. Otto Schwarz. If you knew him you know he approached everything with a quiet elegance, but that never meant he would take no for an answer, if it was in the pursuit of what he believed.

SPEECH OF HON. KEVIN BRADY OF TEXAS IN THE HOUSE OF REPRESENTATIVES

Library of Congress [Page: E979]
Mr. Speaker, I rise today to honor the Plasma Protein Therapeutics Association (PPTA) as that organization celebrates its 20th anniversary.

Dear Sir or Madam:

The Plasma Protein Therapeutics Association ("PPTA" or "Association") commends the Food and Drug Administration ("FDA" or "Agency") for addressing the critical issue of drug shortages through its February 2012 draft Guidance to industry, "Notification to FDA of Issues that May Result in a Prescription Drug or Biological Product Shortage" ("Draft Guidance").

The Plasma Protein Therapeutics Association (PPTA) recognizes World Hemophilia Day, an international event sponsored by the World Federation for Hemophilia (WFH) and designed to raise awareness of people living with inherited bleeding disorders.

ANNAPOLIS, MD – Plasma Protein Therapeutics Association (PPTA) joins over 300 organizations in 56 countries in recognizing International Rare Disease Day. This event, now in its fifth year, seeks to raise awareness among the general public and decision makers about rare diseases, impacting lives all over the globe.

Dear PPTA Stakeholders,

PPTA is pleased to announce that, as of today, reporting of data on the U.S. supply of certain plasma protein therapies has resumed.